Cases 11 - 20 of 32
Otsuka Pharmaceutical Co., Ltd. et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2019cv02065
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2019cv02021
Defendant:
Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc., Alembic Global Holding SA and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim International GmbH et al v. Macleods Pharamceuticals Ltd. et al
as 1:2019cv01864
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2019cv01772
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Intellectual Property GMBH et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2019cv00880
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Bayer Intellectual Property GMBH, Bayer AG and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Macleods Pharmaceuticals Limited et al.
as 1:2019cv00316
Defendant:
Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Limited
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Genentech, Inc. et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2019cv00154
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2018cv01764
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
H. Lundbeck A/S et al v. Lupin Limited, et al
as 1:2018cv00088
Counter Defendant:
Takeda Pharmaceutical Company Ltd.
Plaintiff:
Takeda Pharmaceuticals International AG, H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
Apotex Inc., Apotex Research Private Limited, Apotex Corp. and others
Counter Claimant:
Unichem Laboratories, Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
